Scientists track rare genetic disease to unlock its secrets
NCT ID NCT07213297
Summary
This study aims to better understand hereditary transthyretin amyloidosis, a rare genetic disease where abnormal protein deposits damage organs over time. Researchers will follow 20 adults with confirmed genetic mutations to track how their symptoms develop and change. The study involves regular check-ups and tests to identify patterns in how the disease affects the heart, nerves, and other body systems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS IN TRANSTHYRETIN (TTR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Cuenca Alta de Cañuelas
RECRUITINGCañuelas, Buenos Aires, 1814, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.